Product overview
Semaglutide is a modified GLP-1 analogue/lipopeptide investigated extensively in GLP-1 receptor and
metabolic research.
Research context
Research applications involving GLP-1 receptor signaling, metabolic pathways, energy regulation and related biochemical mechanisms.
Product specifications
Physical form
Lyophilized peptide / Peptide preparation in cartridge format
Molecular formula
C187H291N45O59
Molecular weight
4114 g/mol
Handling & storage
Store according to product-specific stability and handling documentation; protect from heat, moisture and direct light.
Batch documentation / COA
Batch documentation is available for applicable products. Where a Certificate of Analysis is published, verify that the batch number shown on the product corresponds to the batch number stated on the analytical report.
COA status
Available on request
Manufacturing origin
Manufactured in South Korea.
Research use notice
For Laboratory Research Use Only. Not for Human Consumption. Not intended to diagnose, treat, cure, or prevent any disease.